News DFB Healthcare Acquisitions Corp.

Equities

AHCO

US23291E1091

Delayed Nasdaq Other stock markets 11:18:46 2021-10-05 am EDT			5-day change	1st Jan Change
23.49 ^USD	-0.29%		-0.88%	-37.27%

Apr. 17	AdaptHealth Names Suzanne Foster as CEO	MT
Feb. 28	UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference Call	Apr. 18	BU
AdaptHealth Names Suzanne Foster as CEO	Apr. 17	MT
AdaptHealth Appoints Suzanne Foster as Chief Executive Officer	Apr. 17	BU
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating	Feb. 28	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating	Feb. 28	MT
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook	Feb. 28	AQ
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb	Feb. 27	MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M	Feb. 27	MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating	Jan. 29	MT
Peloton Equity Leads Growth Investment in OnPoint Healthcare Partners	Jan. 26	AQ
AHCO DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages AdaptHealth Corp. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AHCO	Dec. 17	NE
AHCO DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AHCO	Dec. 14	NE
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AHCO	Nov. 23	NE
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating	Nov. 08	MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50	Nov. 08	MT
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says	Nov. 08	MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating	Nov. 08	MT
AdaptHealth Corp. Announces Third Quarter 2023 Results	Nov. 08	AQ
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating	Nov. 08	MT
ROSEN, A LEADING AND RANKED FIRM, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AHCO	Nov. 07	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DFB Healthcare Acquisitions Corp.

Equities

AHCO

US23291E1091

Summary

Filters